KZIA
Kazia TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Primary-source evidence supports a cautious upside case built around several real 2026 shots on goal: Q2 FDA path-forward feedback in GBM, 2H neuro-oncology readouts, and 2H breast-cancer efficacy/biomarker updates. March 2026 materials also cited roughly US$46 million of cash, no debt, and runway into 2029 excluding additional or expanded trials, which helps support continued execution [#IR-2026-03-27].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -2.5.
What can break
Clinical evidence remains early and fragile, with the January 2026 TNBC update based on a very small number of patients and no mature randomized efficacy readout yet.
Momentum
95
Value
42
Sentiment
49
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $12.00 · Bull $19.00 · Bear $5.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-28 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $19.00
Why
Momentum95 · Δ7d -2.5
Value42 · Δ7d +0.1
Sentiment49 · Δ7d +10.7
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
95
34% active weight
Current posture
7d trendFlat
Δ7d
-2.5
Δ21d
-4.1
Value
42
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.9
Sentiment
49
33% active weight
Current posture
7d trendImproving
Δ7d
+10.7
Δ21d
+17.6
Why this grade
Composite grade A. Momentum 95.2 / Value 41.9 / Sentiment 48.9
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$142.38M
Beta
1.79
Shares Out
4.56M
P/E (TTM) · Derived
-8.6
P/S (TTM)
802.17
P/FCF (TTM) · Derived
-5.21
Rev YoY
-96.3%
EPS YoY
+96.8%
Gross Margin
-
Op Margin
-21258.8%
Net Debt
-$517.6K
Current Ratio
0.35
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology